Evaluating Clorox: Insights From 11 Financial Analysts
Portfolio Pulse from Benzinga Insights
Clorox (NYSE:CLX) has been evaluated by 11 analysts over the past three months, with a mix of ratings from indifferent to bearish. The average 12-month price target has decreased by 2.54% to $140.55. Analysts have adjusted their ratings and price targets in response to market conditions, with some raising and others lowering their expectations. Clorox's financials show a decline in revenue growth but strong profitability and financial management.

August 28, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Clorox has received mixed analyst ratings, with a decrease in the average price target to $140.55. Analysts have adjusted their ratings in response to market conditions, reflecting a cautious outlook. Despite revenue challenges, Clorox shows strong profitability and financial management.
The mixed analyst ratings and decrease in price target suggest a cautious outlook for Clorox. However, the company's strong profitability and financial management provide a positive counterbalance. The neutral score reflects the balance of these factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100